Chemical Structure (Ery Tab 01)
Ery-tab Tablet, Delayed Release
Product Images NDC 24338-124
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Ery-tab (NDC 24338-124). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Arbor Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Principal Display Panel (250 mg Tablet Bottle Label)
This is a description of a medication called ERY-TAB, which is a type of ERYTHROMYCIN DELAYED-RELEASE TABLETS, USP ENTERIC-COATED. Each tablet contains 250 mg of Erythromycin as the free base. The medication should be stored below 86°F (30°C) and dispensed in a USP tight container. The packaging insert should be consulted for full prescribing information. The medication can be administered without regard to meals. The manufacturer of the medication is Arbor Pharmaceuticals, LLC located in Atlanta, GA.*
Principal Display Panel (333 mg Tablet Bottle Label)
This text is a label of medication for Erythromycin Delayed-Release Tablets. It recommends dispensing it in a USP tight container, keeping it tightly closed and not accepting the bottle if its opening is broken or missing. The tablets contain 333mg of Erythromycin and should be taken according to the full prescribing information included in the package insert. The dosage may be administered without regard to meals.*
Principal Display Panel (500 mg Tablet Bottle Label)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
